The Role of Somatic L1 Retrotransposition in Human Cancers

Por Scott, Emma C., Devine, Scott E.
Publicado no Viruses (2017)

Targeting the programmed cell death 1 pathway in Hodgkin lymphoma: the place of nivolumab

Por Gay, Nathan D., Okada, Craig Y., Chen, Andy I., Scott, Emma C.
Publicado no Ther Adv Hematol (2017)

A hot L1 retrotransposon evades somatic repression and initiates human colorectal cancer

Por Scott, Emma C., Gardner, Eugene J., Masood, Ashiq, Chuang, Nelson T., Vertino, Paula M., Devine, Scott E.
Publicado no Genome Res (2016)

The Mobile Element Locator Tool (MELT): population-scale mobile element discovery and biology

Por Gardner, Eugene J., Lam, Vincent K., Harris, Daniel N., Chuang, Nelson T., Scott, Emma C., Pittard, W. Stephen, Mills, Ryan E., Devine, Scott E.
Publicado no Genome Res (2017)

Small molecule inhibitor screen identifies synergistic activity of the bromodomain inhibitor CPI203 and bortezomib in drug resistant myeloma

Por Siegel, Matthew B., Liu, Selina Qiuying, Davare, Monika A., Spurgeon, Stephen E., Loriaux, Marc M., Druker, Brian J., Scott, Emma C., Tyner, Jeffrey W.
Publicado no Oncotarget (2015)

Partial Correction of the CNS Lysosomal Storage Defect in a Mouse Model of Juvenile Neuronal Ceroid Lipofuscinosis by Neonatal CNS Administration of an Adeno-Associated Virus Serot...

Por Sondhi, Dolan, Scott, Emma C., Chen, Alvin, Hackett, Neil R., Wong, Andrew M.S., Kubiak, Agnieszka, Nelvagal, Hemanth R., Pearse, Yewande, Cotman, Susan L., Cooper, Jonathan D., Crystal, Ronald G.
Publicado em 2014

Efficacy and toxicity of therapy immediately after treatment with nivolumab in relapsed multiple myeloma

Por Pianko, Matthew J., Funt, Samuel A., Page, David B., Cattry, Deepika, Scott, Emma C., Ansell, Stephen M., Borrello, Ivan M., Gutierrez, Martin, Lendvai, Nikoletta, Hassoun, Hani, Landgren, C. Ola, Lesokhin, Alexander M.
Publicado no Leuk Lymphoma (2017)

Differentiation syndrome with ivosidenib and enasidenib treatment in patients with relapsed or refractory IDH-mutated AML: a U.S. Food and Drug Administration systematic analysis

Por Norsworthy, Kelly J., Mulkey, Flora, Scott, Emma C., Ward, Ashley F., Przepiorka, Donna, Charlab, Rosane, Dorff, Sarah, Deisseroth, Albert B., Kazandjian, Dickran, Sridhara, Rajeshwari, Beaver, Julia A., Farrell, Ann T., de Claro, R. Angelo, Pazdur, Richard
Publicado no Clin Cancer Res (2020)

Double autophagy stimulation using chemotherapy and mTOR inhibition combined with hydroxychloroquine for autophagy modulation in patients with relapsed or refractory multiple myelo...

Por Scott, Emma C., Maziarz, Richard T., Spurgeon, Stephen E., Medvedova, Eva, Gajewski, James, Reasor-Heard, Shara, Park, Byung, Kratz, Anne, Thomas, George V., Loriaux, Marc, Cascio, Michael, Podolak, Jennifer, Gordon, Miranda, Botelho, Jennifer, Stadtmauer, Edward, Amaravadi, Ravi, Vogl, Dan T.
Publicado no Haematologica (2017)

Combined autophagy and proteasome inhibition: A phase 1 trial of hydroxychloroquine and bortezomib in patients with relapsed/refractory myeloma

Por Vogl, Dan T, Stadtmauer, Edward A, Tan, Kay-See, Heitjan, Daniel F, Davis, Lisa E, Pontiggia, Laura, Rangwala, Reshma, Piao, Shengfu, Chang, Yunyoung C, Scott, Emma C, Paul, Thomas M, Nichols, Charles W, Porter, David L, Kaplan, Janeen, Mallon, Gayle, Bradner, James E, Amaravadi, Ravi K
Publicado em 2014

PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma

Por Ansell, Stephen M., Lesokhin, Alexander M., Borrello, Ivan, Halwani, Ahmad, Scott, Emma C., Gutierrez, Martin, Schuster, Stephen J., Millenson, Michael M., Cattry, Deepika, Freeman, Gordon J., Rodig, Scott J., Chapuy, Bjoern, Ligon, Azra H., Zhu, Lili, Grosso, Joseph F., Kim, Su Young, Timmerman, John M., Shipp, Margaret A., Armand, Philippe
Publicado no N Engl J Med (2014)

Nivolumab in Patients With Relapsed or Refractory Hematologic Malignancy: Preliminary Results of a Phase Ib Study

Por Lesokhin, Alexander M., Ansell, Stephen M., Armand, Philippe, Scott, Emma C., Halwani, Ahmad, Gutierrez, Martin, Millenson, Michael M., Cohen, Adam D., Schuster, Stephen J., Lebovic, Daniel, Dhodapkar, Madhav, Avigan, David, Chapuy, Bjoern, Ligon, Azra H., Freeman, Gordon J., Rodig, Scott J., Cattry, Deepika, Zhu, Lili, Grosso, Joseph F., Bradley Garelik, M. Brigid, Shipp, Margaret A., Borrello, Ivan, Timmerman, John
Publicado no J Clin Oncol (2016)

Post-transplant outcomes in high-risk compared to non-high risk multiple myeloma, a CIBMTR analysis

Por Scott, Emma C., Hari, Parameswaran, Sharma, Manish, Le-Rademacher, Jennifer, Huang, Jiaxing, Vogl, Dan, Abidi, Muneer, Beitinjaneh, Amer, Fung, Henry, Ganguly, Siddhartha, Hildebrandt, Gerhard, Holmberg, Leona, Kalaycio, Matt, Kumar, Shaji, Kyle, Robert, Lazarus, Hillard, Lee, Cindy, Maziarz, Richard T., Meehan, Kenneth, Mikhael, Joseph, Nishihori, Taiga, Ramanathan, Muthalagu, Usmani, Saad, Tay, Jason, Vesole, David, Wirk, Baldeep, Yared, Jean, Savani, Bipin N., Gasparetto, Cristina, Krishnan, Amrita, Mark, Tomer, Nieto, Yago, D’Souza, Anita
Publicado no Biol Blood Marrow Transplant (2016)

Outcomes of Patients with Multiple Myeloma Refractory to CD38-Targeted Monoclonal Antibody Therapy

Por Gandhi, Ujjawal H, Cornell, Robert F, Lakshman, Arjun, Gahvari, Zhubin J, McGehee, Elizabeth, Jagosky, Megan H, Gupta, Ridhi, Varnado, William, Fiala, Mark A, Chhabra, Saurabh, Malek, Ehsan, Mansour, Joshua, Paul, Barry, Barnstead, Alyssa, Kodali, Saranya, Neppalli, Amarendra, Liedtke, Michaela, Narayana, Swapna, Godby, Kelly N, Kang, Yubin, Kansagra, Ankit, Umyarova, Elvira, Scott, Emma C, Hari, Parameswaran, Vij, Ravi, Usmani, Saad Z, Callander, Natalie S, Kumar, Shaji K, Costa, Luciano J
Publicado no Leukemia (2019)

Improved Outcomes After Autologous Hematopoietic Cell Transplantation for Light Chain Amyloidosis: A Center for International Blood and Marrow Transplant Research Study

Por D'Souza, Anita, Dispenzieri, Angela, Wirk, Baldeep, Zhang, Mei-Jie, Huang, Jiaxing, Gertz, Morie A., Kyle, Robert A., Kumar, Shaji, Comenzo, Raymond L., Peter Gale, Robert, Lazarus, Hillard M., Savani, Bipin N., Cornell, Robert F., Weiss, Brendan M., Vogl, Dan T., Freytes, César O., Scott, Emma C., Landau, Heather J., Moreb, Jan S., Costa, Luciano J., Ramanathan, Muthalagu, Callander, Natalie S., Kamble, Rammurti T., Olsson, Richard F., Ganguly, Siddhartha, Nishihori, Taiga, Kindwall-Keller, Tamila L., Wood, William A., Mark, Tomer M., Hari, Parameswaran
Publicado no J Clin Oncol (2015)

Staging Systems for Newly Diagnosed Myeloma Patients Undergoing Autologous Hematopoietic Cell Transplantation: The Revised International Staging System Shows the Most Differentiati...

Por Scott, Emma C., Hari, Parameswaran, Kumar, Sathish, Fraser, Raphael, Davila, Omar, Shah, Nina, Gale, Robert Peter, Diaz, Miguel Angel, Agrawal, Vaibhav, Cornell, Robert F., Ganguly, Siddhartha, Akpek, Gorgun, Freytes, Cesar, Hashmi, Shahrukh, Malek, Ehsan, Kamble, Rammurti T., Lazarus, Hillard, Solh, Melhem, Usmani, Saad Z., Kanate, Abraham S., Saad, Ayman, Chhabra, Saurabh, Gergis, Usama, Cerny, Jan, Kyle, Robert A., Lee, Cindy, Kindwall-Keller, Tamila, Assal, Amer, Hildebrandt, Gerhard C., Holmberg, Leona, Maziarz, Richard T., Nishihori, Taiga, Seo, Sachiko, Kumar, Shaji, Mark, Tomer, D’Souza, Anita
Publicado no Biol Blood Marrow Transplant (2018)

Daratumumab plus bortezomib and dexamethasone versus bortezomib and dexamethasone in relapsed or refractory multiple myeloma: updated analysis of CASTOR

Por Spencer, Andrew, Lentzsch, Suzanne, Weisel, Katja, Avet-Loiseau, Hervé, Mark, Tomer M., Spicka, Ivan, Masszi, Tamas, Lauri, Birgitta, Levin, Mark-David, Bosi, Alberto, Hungria, Vania, Cavo, Michele, Lee, Je-Jung, Nooka, Ajay K., Quach, Hang, Lee, Cindy, Barreto, Wolney, Corradini, Paolo, Min, Chang-Ki, Scott, Emma C., Chanan-Khan, Asher A., Horvath, Noemi, Capra, Marcelo, Beksac, Meral, Ovilla, Roberto, Jo, Jae-Cheol, Shin, Ho-Jin, Sonneveld, Pieter, Soong, David, Casneuf, Tineke, Chiu, Christopher, Amin, Himal, Qi, Ming, Thiyagarajah, Piruntha, Sasser, A. Kate, Schecter, Jordan M., Mateos, Maria-Victoria
Publicado no Haematologica (2018)